Mood Disorders News

Brintellix, a vortioxetine product approved to treat major depressive disorder in adults, will be marketed in the United States under a new name, Trintellix, starting in June 2016, according to a company press release.

BALTIMORE — Youth who experienced multiple types of bullying were more likely to exhibit aggressive behaviors than those who experienced only one type of bullying, according to data presented at the Pediatric Academic Societies Meeting.

BALTIMORE — Mental health diagnoses and care significantly increased among military-connected children within the last 15 years, according to data presented at the Pediatric Academic Societies Meeting.

The FDA has issued a complete response letter for Digital Medicine, a drug/device combination product from Otsuka Pharmaceutical Inc. and Proteus Digital Health that combines an atypical antipsychotic and an ingestible sensor.

Interpersonal psychotherapy was effective for acute treatment of depression and may also be effective for eating disorders and anxiety disorders, according to recent findings.

Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder — for up to 10 years, according to the results of a matched cohort study conducted in Sweden.

Set-shifting performance predicted response to aripiprazole augmentation among older adults with treatment-resistant depression, according to recent findings.

Mindfulness-based cognitive therapy was effective for relapse prevention among individuals with recurrent depression, particularly those with more prominent residual symptoms.

Escitalopram delayed time to relapse and lowered risk for relapse among adults with body dysmorphic disorder, according to recent findings.

Twice-weekly and thrice-weekly IV administration of ketamine maintained similar antidepressant efficacy over 15 days among adults with treatment-resistant depression, according to recent findings.